MiR-29a Knockout Aggravates Neurological Damage by Pre-polarizing M1 Microglia in Experimental Rat Models of Acute

Fangfang Zhao1,2, Haiping Zhao1,2, Junfen Fan1,2

  • 1Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.

Frontiers in Genetics
|April 1, 2021
PubMed
Abstract

Insights

Knocking out miR-29a-5p in rats worsened neurological damage after ischemic stroke by increasing microglial activation and glutamate release. This highlights miR-29a-5p

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Acute ischemic stroke causes significant neurological damage.
  • MicroRNAs play crucial roles in regulating cellular responses to injury.
  • Understanding the specific roles of microRNAs like miR-29a-5p is vital for developing targeted therapies.

Purpose of the Study:

  • To investigate the functional role of miR-29a-5p in the context of acute ischemic stroke.
  • To elucidate the molecular mechanisms underlying miR-29a-5p's influence on post-ischemic brain injury.
  • To explore miR-29a-5p as a potential therapeutic target for ischemic stroke.

Main Methods:

  • Establishment of a transient middle cerebral artery occlusion (MCAO) model in miR-29a-5p knockout and wild-type rats.
  • Quantification of miR-29a-5p expression in plasma, brain tissue, and immune cells using real-time PCR.
  • Assessment of infarct volume (TTC staining) and glial cell activation (Western blotting) in MCAO models.

Main Results:

  • miR-29a-5p expression was significantly decreased in the blood and brain of MCAO rat models and in stroke patients.
  • miR-29a-5p knockout exacerbated infarct volume and promoted M1 microglial polarization in the MCAO rat brain.
  • Loss of miR-29a-5p led to increased astrocyte proliferation and glutamate release, contributing to heightened neurological damage.

Conclusions:

  • miR-29a-5p knockout aggravates neurological damage in experimental stroke models.
  • The mechanism involves promoting M1 microglial polarization and increasing glutamate release.
  • Targeting miR-29a-5p may offer a novel therapeutic strategy for ischemic brain injury.

Related Concept Videos